SeaStar Medical Holding Corp

SeaStar Medical Holding Corp (Nasdaq: LMAO) is a medical-device company that completed its business combination with blank-check vehicle LMF Acquisition Opportunities, Inc. in October 2022, the transaction reflected in the 8-K filed on October 17 of that year. The SPAC, sponsored by LMF Acquisition Opportunities LLC, had completed its initial public offering in 2021 and targeted the healthcare and life-sciences sector. SeaStar Medical develops the Selective Cytopheretic Device, a blood-purification technology intended for critically ill patients with acute kidney injury. The company currently trades on Nasdaq under the LMAO ticker following the closing of the de-SPAC transaction. For full filing history, deal terms, and real-time status on SeaStar Medical and hundreds of other SPAC transactions, sign up for complete access at SpacDesk.